Oxtoby Andrew

Oxtoby Andrew is listed in filings as See Remarks at Kalaris Therapeutics Inc. This profile follows SEC Form 4 activity through Mar 20, 2026, including 3 public disclosures. Recent filings connect the profile to Kalaris Therapeutics Inc (KLRS). The current snapshot covers public activity from Mar 18, 2025 to Mar 20, 2026. Reported amounts are shown as $405.1K to $1.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.